Cycloserine plus ethionamide in the treatment of patients excreting isoniazid-resistant tubercle bacilli following previous chemotherapy.
D000328:Adult; D003523:Cycloserine / Q000009:adverse effects / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D005000:Ethionamide / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000494:pharmacology*; D008297:Male; D013183:Sputum / Q000382:microbiology; D013307:Streptomycin / Q000494:pharmacology; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D003523:Cycloserine; D005000:Ethionamide; D007538:Isoniazid; D013307:Streptomycin